# "First-in-human" Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers

> **NCT01845181** · PHASE1 · COMPLETED · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 32 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** PBF-680
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01845181
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-08
- **Final completion:** 2013-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01845181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01845181, ""First-in-human" Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01845181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*